# Kyowa Kirin Bio doubles down on medical amino acids at Asian units - Nikkei Asia

> Kyowa Hakko Bio plans to invest 10 billion yen (about $91.1 million) by 2020 to double capacity at its Chinese and Thai plants. The plants make amino acids for medical care. The company cites growing demand in emerging countries.

- Date: 2017-08-18 · published 2017-08-18T12:00:00.000Z
- Category: market · region Asia · magnitude low
- Page: https://feedsoft.ai/events/69778-kyowa-kirin-bio-doubles-down-on-medical-amino-acids-at-asian-units-nikkei-asia
- Commodities: [Lysine](https://feedsoft.ai/c/LYSINE.md)

## Why it matters

The expansion targets medical-grade amino acids rather than feed grades, so the direct effect on feed amino acid supply and prices is minimal.

## Sources

- asia.nikkei.com: https://asia.nikkei.com/business/kyowa-kirin-bio-doubles-down-on-medical-amino-acids-at-asian-units

---
Data from Feedsoft AI (https://feedsoft.ai/). For information only; not investment advice.